ORBIMED ADVISORS LLC 13D and 13G filings for 89bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-16 4:25 pm Sale |
2023-05-15 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 3,777,778 4.800% |
-482,913 (-11.33%) |
Filing |
| 2023-03-24 4:43 pm Sale |
2023-03-22 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 0 0.000% |
-1,504,436 (Position Closed) |
Filing |
| 2023-01-26 4:40 pm Sale |
2023-01-24 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,504,436 3.200% |
-325,000 (-17.77%) |
Filing |
| 2022-12-27 4:25 pm Sale |
2022-12-22 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 4,260,691 5.600% |
-767,483 (-15.26%) |
Filing |
| 2022-08-12 2:29 pm Purchase |
2022-08-10 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 5,028,174 6.900% |
5,028,174 (New Position) |
Filing |
| 2022-07-05 4:30 pm Sale |
2022-07-05 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,829,436 4.700% |
-35,285 (-1.89%) |
Filing |
| 2020-09-23 5:00 pm Sale |
2020-09-21 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,864,721 9.400% |
-137,500 (-6.87%) |
Filing |
| 2020-07-13 4:20 pm Unchanged |
2020-07-10 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 2,002,221 11.900% |
0 (Unchanged) |
Filing |